Tumor-Selective Activation of Toll-Like Receptor 7/8 Agonist Nano-Immunomodulator Generates Safe Anti-Tumor Immune Responses upon Systemic Administrat_Citations

TEL： +86 571 56623320 EMAIL： [email protected]

my cart0
0 products in your cart, total money $0.00.
login
register

All categories

Quick Step Elisa kit >

Human elisa kit

Rat Elisa kit

Mouse Elisa Kit

Others Elisa kit

Qualitative elisa kit
ELISA KIT >

HCP RD Kit

Human Elisa Kit

Rat Elisa Kit

Mouse Elisa Kit

Rabbit Elisa Kit

Sheep Elisa Kit

Goat Elisa Kit

Bovine Elisa Kit

Pig Elisa kit

Horse Elisa Kit

Chicken Elisa Kit

Fish Elisa Kit

Duck Elisa kit

Canine Elisa Kit

General Elisa Kit

Porcine Elisa Kit

Other Elisa Kit
Sunlong Medical™ >

ELISA KIT

One Step ELISA KIT

High Sensitivity ELISA Kit
Assay-Detection Kit >
Antibody >

KO-KD Validated Antibody

Primary Antibody

Secondary Antibody

Marker Primary Antibody

Marker Secondary Antibody
Protein >

Native Protein

Active Protein

Recombinant Protein

Eukaryotic protein

Polypeptide

Modified protein

Couple Small Molecules
Extraction Kit >
PCR KIT >

Mycoplasma PCR Kit

Chlamydia PCR Kit

Regular Pcr
IHC Kit >
Enyme, Coenzyme >
Cytokine Reagent >

Your Position: Home > Citations > Tumor-Selective Activation of Toll-Like Receptor 7/8 Agonist Nano-Immunomodulator Generates Safe Anti-Tumor Immune Responses upon Systemic Administrat

Return and refund policy

Tumor-Selective Activation of Toll-Like Receptor 7/8 Agonist Nano-Immunomodulator Generates Safe Anti-Tumor Immune Responses upon Systemic Administrat

SUNLONG BIOTECH / 2024-01-09